e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of a new walking aid on 6MWD in COPD patients
A. W. Vaes, J. Annegarn, K. Meijer, M. W. Cuijpers, F. M. E. Franssen, J. Wiechert, E. F. M. Wouters, M. A. Spruit (Horn, Maastricht, Netherlands)
Source:
Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Session:
Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Session type:
Oral Presentation
Number:
209
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. W. Vaes, J. Annegarn, K. Meijer, M. W. Cuijpers, F. M. E. Franssen, J. Wiechert, E. F. M. Wouters, M. A. Spruit (Horn, Maastricht, Netherlands). Effects of a new walking aid on 6MWD in COPD patients. Eur Respir J 2011; 38: Suppl. 55, 209
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Why do COPD patients improve six minute walking distance (6MWD) with the use of a rollator?
Source: Eur Respir J 2003; 22: Suppl. 45, 330s
Year: 2003
The 6-minute walking distance parameters in COPD patients during biennium research
Source: Eur Respir J 2006; 28: Suppl. 50, 807s
Year: 2006
Is 6-min walk distance more helpful than FEV1 in evaluating severe COPD patients?
Source: ISSN=ISSN 1810-6838, ISBN=, page=68
Year: 2007
Efficacy of walking aids during self-paced outdoor walking in COPD patients
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013
Impact of pulmonary rehabilitation on six-minute walk distance in patients with very severe COPD
Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention
Year: 2010
Predictors of six-minute walk distance at baseline and after three years in COPD patients
Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Year: 2011
Effects of home-based pulmonary rehabilitation on the time spent in active- and passive- walking in elderly patients with COPD
Source: Annual Congress 2012 - The best abstracts in pulmonary rehabilitation
Year: 2012
The 6-min walking distance: long-term follow up in patients with COPD
Source: Eur Respir J 2007; 29: 535-540
Year: 2007
Anti-inflammatory nutritional support enhances exercise performance and QOL in patients with stable COPD
Source: Annual Congress 2011 - The best abstracts in rehabilitation and chronic care 2011 (sponsored by Nutricia Advanced Medical Nutrition)
Year: 2011
Variability in walking patterns during the 6MWT in COPD patients and healthy controls
Source: Annual Congress 2011 - Clinical physiology for clinical problems
Year: 2011
Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008
Predictors for longitudinal change in 6-minute walk distance in COPD patients
Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation
Year: 2012
Comparison of 2- versus 6-minute walking test in patients with severe COPD
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Is pulmonary rehabilitation impact different regarding the 6 minute walk test distance in hypercapnic COPD patients?
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017
Influence of hospitalizations because of COPD exacerbation in the six-minute walk test (6MWT)
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Determinants of the 6 minute walking distance and exercise desaturations in COPD: relationships with comorbidities
Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases
Year: 2017
The impact of body composition on walking distance in the six-minute walk test in COPD patients
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Validation of the current equations to estimate peak work load based on 6-min walk distance and general demographics in COPD patients entering pulmonary rehabilitation
Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept